Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NMBL

(NMBL) (NMBL) Stock Price, News & Analysis

(NMBL) logo

About (NMBL) Stock (NYSE:NMBL)

Advanced Chart

Key Stats

Today's Range
$12.49
$12.49
50-Day Range
N/A
52-Week Range
$6.18
$12.58
Volume
N/A
Average Volume
2.65 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NMBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NMBL) and its competitors with MarketBeat's FREE daily newsletter.

NMBL Stock News Headlines

Evoke PLC EVOK
Biotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B market
A small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of the market’s most overlooked opportunities today. NanoViricides, Inc. (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral now in human trials, with activity against COVID-19, RSV, influenza, measles, and most recently Mpox. With Phase II trials approved in Africa for the deadliest Mpox strain, the timing couldn’t be more critical.
EMC Corp. to Be Acquired by Dell for $67B
See More Headlines

NMBL Stock Analysis - Frequently Asked Questions

(NMBL) (NYSE:NMBL) posted its earnings results on Tuesday, August, 23rd. The technology company reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.20) by $0.01. The firm's revenue for the quarter was up 21.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that (NMBL) investors own include OPKO Health (OPK), TherapeuticsMD (TXMD), bluebird bio (BLUE), Gray Media (GTN), Pure Storage (PSTG), Allergan (AGN) and Bausch Health Cos (BHC).

Company Calendar

Last Earnings
8/23/2016
Today
8/18/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:NMBL
CIK
1452751
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:NMBL) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners